ANRS C04 FHDH - French hospital database on HIV
Head :
Costagliola Dominique, U 943 Épidémiologie, stratégies thérapeutiques et virologie clinique dans l'infection à VIH <br/>Inserm et UPMC
Krause Mary, U943, EPIDÉMIOLOGIE, STRATÉGIES THÉRAPEUTIQUES ET VIROLOGIE CLINIQUE DANS L'INFECTION À VIH INSERM ET UPMC
Krause Mary, U943, EPIDÉMIOLOGIE, STRATÉGIES THÉRAPEUTIQUES ET VIROLOGIE CLINIQUE DANS L'INFECTION À VIH INSERM ET UPMC
Last update : 05/13/2015 | Version : 5 | ID : 60047
| General | |
| Identification | |
| Detailed name | French hospital database on HIV |
| Sign or acronym | ANRS C04 FHDH |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | CNIL : 27/11/1991 |
| General Aspects | |
| Medical area |
Cancer research Cardiology Immunology Infectious diseases |
| Health determinants |
Geography |
| Keywords | health episodes, morbidity, mortality, HIV, pharmacology, prevention |
| Scientific investigator(s) (Contact) | |
| Name of the director | Costagliola |
| Surname | Dominique |
| Address | 75625 PARIS 13 |
| Phone | +33 (0)1 42 16 42 82 |
| dcostagliola@ccde.chups.jussieu.fr | |
| Unit | U 943 Épidémiologie, stratégies thérapeutiques et virologie clinique dans l'infection à VIH <br/>Inserm et UPMC |
| Organization | DHOS |
| Name of the director | Krause |
| Surname | Mary |
| Address | 75625 PARIS 13 |
| Phone | + 33 (0)1 42 16 42 76 |
| mmary@ccde.chups.jussieu.fr | |
| Unit | U943, EPIDÉMIOLOGIE, STRATÉGIES THÉRAPEUTIQUES ET VIROLOGIE CLINIQUE DANS L'INFECTION À VIH INSERM ET UPMC |
| Organization | DHOS |
| Collaborations | |
| Participation in projects, networks and consortia |
Yes |
| Funding | |
| Funding status |
Mixed |
| Details | Inserm, ANRS, SIDACTION, ABBOTT, JANSSEN, BMS, GILEAD,... |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | DHOS |
| Organisation status |
Public |
| Additional contact | |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Prospective |
| Database objective | |
| Main objective | General objective: To evaluate the medium and long-term clinical impact of therapeutic strategies with the help of marginal structural models. Secondary objectives - to assess non-AIDS-defining morbidity and mortality and the impact of HIV infection and/or treatment for cancer as well as vascular and metabolic diseases. - to contribute to epidemiological monitoring of HIV infection in France (descriptive epidemiology and establishment of model). - to participate in international collaborations on treated patient prognosis as well as morbidity and mortality in previously diagnosed individuals. |
| Inclusion criteria | Individuals over 15 infected with HIV-1 or 2 that attended one of the participating centres at least once since 1987 |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) |
| Population covered |
Sick population |
| Gender |
Male Woman |
| Geography area |
National |
| Detail of the geography area | French multi-centre cohort (62 centres). Throughout all of France including overseas territories. Aquitaine not included. |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 01/1987 |
| Size of the database | |
| Size of the database (number of individuals) |
Greater than 20 000 individuals |
| Details of the number of individuals | 120838 |
| Data | |
| Database activity |
Data collection completed |
| Type of data collected |
Clinical data |
| Clinical data (detail) |
Medical registration |
| Presence of a biobank |
No |
| Health parameters studied |
Health event/morbidity Health event/mortality |
| Procedures | |
| Data collection method | Clinical examinations: handwritten (manual input) Biological analysis: handwritten |
| Participant monitoring |
Yes |
| Details on monitoring of participants | (Indefinite duration) |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Link to the document | http://www.hal.inserm.fr/ANRSCO4 |
| Description | List of publications in HAL |
| Link to the document | http://tinyurl.com/Pubmed-Publication-ANRSCO4 |
| Description | List of publications in Pubmed |
| Access | |
| Terms of data access (charter for data provision, format of data, availability delay) | Data may be used by academic teams Data may be used by industrial teams |
| Access to aggregated data |
Access on specific project only |
| Access to individual data |
Access on specific project only |
